Diversified Consumer Services
Company Overview of Johns Hopkins University
Johns Hopkins University is an educational institution offering undergraduate, graduate, part-time, summer, and distance education programs. The school of the university includes Krieger School of Arts and Sciences, Whiting School of Engineering, School of Professional Studies in Business and Education, School of Medicine, School of Nursing, Bloomberg School of Public Health, Nitze School of Advanced International Studies, The Peabody Institute, and Applied Physics Laboratory. Johns Hopkins University was established in 1876 and is based in Baltimore, Maryland. The university has endowment assets worth $2608.5 millions.
3400 North Charles Street
Baltimore, MD 21218-2683
Founded in 1876
Key Executives for Johns Hopkins University
Senior Associate Dean for Finance & Administration and Senior Associate Dean for Krieger School of Arts & Sciences
Executive Director of Communications and Public Affairs
Vice President of Communications and Public Affairs
Compensation as of Fiscal Year 2014.
Johns Hopkins University Key Developments
Johns Hopkins Medicine Appoints Robert A. Kasdin as Senior Vice President and Chief Operating Officer
May 13 15
Johns Hopkins Medicine announced the appointment of Robert A. Kasdin to the newly created role of senior vice president and chief operating officer. Kasdin comes to Johns Hopkins Medicine from Columbia University, where he has been senior executive vice president since 2002. He starts on July 1, 2015. As Johns Hopkins Medicine's first senior vice president and chief operating officer, Kasdin will partner with leadership to drive organization-wide change within a rapidly evolving environment. He will be responsible for overall operations, including strategic direction, administration of existing programs and development of new initiatives to ensure that Johns Hopkins Medicine's strategic imperatives are achieved or exceeded.
Johns Hopkins University Presents at IFC’s 17th Annual Global Private Equity Conference, May-11-2015 02:30 PM
May 8 15
Johns Hopkins University Presents at IFC’s 17th Annual Global Private Equity Conference, May-11-2015 02:30 PM. Venue: The Ritz-Carlton, Washington, District Of Columbia, United States. Speakers: Roger Leeds, Professor, Johns Hopkins University and Founding Chairman, EMPEA.
MaxCyte Inc. and Johns Hopkins University Announce Strategic Immuno-Oncology Collaboration to Advance CAR T-Cell Therapies
Apr 21 15
MaxCyte Inc. announced a strategic research collaboration with Johns Hopkins University (JHU) to develop unique Chimeric Antigen Receptor (CAR) T-cell therapies, which harness patients own immune systems to combat cancers. MaxCyte's unique approach to CAR cell therapy allows targeting of solid tumor cancers by enabling control over the on-target, off-tumor toxicity, which limits other CAR therapies to hematological cancers. MaxCyte achieves this by introducing the CAR construct as a transiently expressing messenger RNA (mRNA), thus allowing control of the duration of expression and toxicity against target antigens in normal tissue. This unique approach also avoids the cell expansion step required for standard approaches, dramatically reducing manufacturing time and expense for CAR therapies from days or weeks to a matter of hours. The preclinical work performed in collaboration with JHU will support a future planned Investigational New Drug (IND) filing for a CAR therapy targeting a broad range of solid tumors. No financial terms are disclosed.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|